My Creative and Theatrical Fitness Plan

BWW Blog: My Creative and Theatrical Fitness Plan
Cassie Maurer and her pup Chanel
helping her with homework
back in the beginning of
quarantine this March.

Ah, the holidays. Every year come late November, we BFA college students enter a sedentary period known as: winter break. Speaking for myself, at least. I morph from active, driven student almost instantly to couch potato. I’ve made it a goal of mine this year for that not to be the case. As opposed to sitting and watching Hallmark Christmas movies all day (though, trust me, I will absolutely be finding time to do this!), I’ve decided to make a fitness plan for myself to follow. But not just any fitness plan, no! This fitness plan is for working my creative and theatrical muscles while away from school… and I suppose I should exercise my physical muscles, as well. Keeping in mind, though, that this is called “winter break” for a reason, I will strive to achieve balance and not overwork myself.

Maybe it’s just me and my relationship with my family, but every time I come home, I feel as though I am being demanded to perform: “Sing us a song, Cassie! C’mon we sent you off to school to do this; can’t you just sing a little for us right now, pleeeease?!” It’s constant. Naturally, I tell them no, and I am met with displeasure. (Don’t worry! They won’t be shocked that I’m writing this; I’ve confronted them about it plenty of times. I think (and hope) by now they know that I won’t do tricks on command like a circus animal.) Anyways, ever since beginning my training in college, I have found it difficult to exercise my voice whilst at home. In fact, whenever I do just shut my door and sing, I’ll often open my door afterward to see my dad sitting there listening (very cute and supportive, I know, but no privacy!). I caught my mother and sister doing this today actually! How timely! Thankfully, I’ve sort of gotten used to that feeling due to recent circumstances. Because of the pandemic, all of my voice lessons, and my those of my roommates, were moved online, so I’ve grown accustomed to singing in my room and hearing them right outside my door. They, however, are Musical Theatre majors like me, so if I crack or fudge something, then I know that they understand. Judging from their commentary while watching American Idol, I’m not sure that my family understands quite the same… That’s what always makes me nervous. Despite this, though, I will sing this break! Here is my vocal exercise plan:

  • Daily: Vocal functions before bed.

  • Weekly: Follow a recorded lesson. Do vocalese and revisit a song.

  • Whenever possible: Sing in the car sans plan or judgement.

  • Whenever I remember: Releasing my jaw and tongue while not singing. And practicing raspberries for releasing tongue tension!

Acting gets trickier to practice at home, as well. After all, it’s not like I can just give myself an acting class. Thinking

Read more

Harley Street dentist says he ‘didn’t plan to have sex with patient at Savoy hotel’

A Harley Street dentist to the stars who slept with a patient after wining and dining her at the Savoy said he only had a condom with him to carry water in an emergency.

Dr Sahil Patel, 28, said he had the contraceptive in his bag ‘for several years’ after attending a survival course.

The dentist twice met up with the woman at a pub in north London after providing her with his mobile phone number.

He then took the patient out to dinner at the Savoy on November 1 last year after completing her veneer treatment.

They carried on drinking until after midnight, when the dentist said he could not get home ‘as there are no underground trains,’ the General Dental Council heard.

Dr Sahil Patel (pictured), a Harley Street dentist to the stars who slept with a patient after wining and dining her at the Savoy, said he only had a condom with him to carry water in an emergency. Dr Patel, 28, said he had the contraceptive in his bag 'for several years' after attending a survival course, the General Dental Council heard today

Dr Sahil Patel (pictured), a Harley Street dentist to the stars who slept with a patient after wining and dining her at the Savoy, said he only had a condom with him to carry water in an emergency. Dr Patel, 28, said he had the contraceptive in his bag ‘for several years’ after attending a survival course, the General Dental Council heard today

The dentist twice met up with the woman at a pub in north London after providing her with his mobile number. He then took the patient out to dinner at the Savoy on November 1 last year after completing her veneer treatment. They carried on drinking until after midnight, when Dr Patel said he could not get home 'as there are no underground trains,' the tribunal heard

The dentist twice met up with the woman at a pub in north London after providing her with his mobile number. He then took the patient out to dinner at the Savoy on November 1 last year after completing her veneer treatment. They carried on drinking until after midnight, when Dr Patel said he could not get home ‘as there are no underground trains,’ the tribunal heard

Dr Patel then went to the patient’s hotel room across the street and had sex with her, the tribunal heard.

The dentist is said to have referred to the woman a ‘Jewish princess’ but he denies using the phrase.

The disciplinary hearing is being held in Marylebone, central London, near The Harley Street Smile Clinic, where Dr Patel is an associate dentist.

The clinic lists former Everton and Scotland striker Andy Gray among its clients as well as TOWIE stars including Lauren Pope, James Lock, Frankie Essex and Kirk Norcross.

Giving evidence, Dr Patel admitted if the condom ‘was present without context then, yes it would show pre-planning’.

But he maintained he kept it ‘in a field craft kit which has been in my bag for several years, incidentally, since attending a training course. It’s used for water retention’.

He claimed ‘Patient A’ asked him to have sex a second time at the hotel.

In his witness statement, he said he turned her down because he was tired, and added today, ‘We couldn’t anyway, due to a lack of contraception’.

Dr Patel is said to have passed her his mobile number on September 27 last year and gone for a drink with her at the White Horse Pub in Parsons Green, south-west London.

Giving evidence, Dr Patel admitted if the condom 'was present without context then, yes it would show pre-planning'. But he maintained he kept it 'in a field craft kit which has been in my bag for several years, incidentally, since attending a training course. It's used for water retention'. Pictured: The General Dental Council building

Giving evidence, Dr Patel admitted if the condom ‘was present without context then, yes it would show pre-planning’. But he maintained he kept it ‘in a field craft kit which has been in

Read more

Precision Medicine Market Sets 2025 Economic Growth Target with Higher Percent, a Post-COVID 19 Plan

The MarketWatch News Department was not involved in the creation of this content.

According to the 2020 Market Research Future Survey, the analysts saw 12.48% of business growth in the Global Precision Medicine Market 2020 is expected to register. Five months later, in May 2020, as the COVID-19 pandemic spread worldwide, there was less possibility that business was having a favorable impact on a broader note. The analysts further studied that the market can reach a valuation of USD 126.14 Billion by 2025. The entire growth scenario is predicted to take place during the years 2014-2022.

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @

Precision Medicine–Boomers & Decliners

The field of precision medicine has made extensive progress with prime discoveries such as microarray/ biochips and single nucleotide polymorphism. These advancements in healthcare have been beneficial for patients to the core of the pharmaceutical industry as well as society. The advent of precision medicine has made researchers understand the method of patients clinical profiles. Human genome research is the future of precision medicine as it owes maximum potential to modify medical treatments for individual patients through the understanding of molecular profiles, genetics, and clinical characteristics in determining the treatment. These factors have made the precision medicine market more robust and stable during the COVID 19 pandemic period.

MRFR’s report presents the factor rising prevalence of cancer to be projected as a booster for personalized cancer diagnostics and therapeutics demands that will leave a positive impact on theprecision medicine market growth. As per a recently published article, in 2018, in the U.S., roughly 1.7 million cases were diagnosed with cancer alone. Apart from this, more factors propelling the growth of this market are escalating online collaborative forums, rising efforts to characterize genes and advancements in cancer biology.

Furthermore, precision medicine applications are chiefly directed toward better treatment against oncological diseases, with an estimated 30% and above market leadership over other segments. According to the data reported in, the United States and a few European countries are the foremost hubs for conducting and recruiting patient pool for precision medicine applications in oncology globally. The elevated support from the government through funding and rapid growth of genomic analysis might boost the development of the precision medicine market at a fast velocity in the forecast period.

Precision Medicine Market Segment Review

The global precision medicine market has been studied under ecosystem players, sub-markets, and therapeutics.

By the segment of ecosystem players, the global precision medicine market has included diagnostic companies, pharmaceuticals and biotechnology companies, clinical laboratories, and healthcare IT specialists/big data companies. The diagnostic tool companies segment grabbed a market value of USD 16.27 million back in 2017.

By the segment of sub-markets, the market has included molecular diagnostics, companion diagnostics, biomarker-based tests, targeted therapeutics, pharmacogenomics (PGX), and others.

By the segment of therapeutics, the market has included cardiovascular disease (CVD), cancer/oncology, infectious diseases, central nervous system, and others.

Precision Medicine Market Regional Aspect

North America presently

Read more

Cuomo, other leaders say federal vaccine plan shortchanges minority areas

The federal plan to roll out a COVID-19 vaccine is woefully inadequate and will shortchange communities of color, said Gov. Andrew M. Cuomo, Attorney General Letitia James and leaders of two prominent national civil rights organizations Sunday.

“COVID has revealed from the very beginning the underlying injustice and inequity in this society,” Cuomo said during a teleconference with reporters where he also gave an update on the state’s ongoing effort to tamp down the coronavirus.

The governor was joined by on the call by James, National Urban League President and Chief Executive Officer Marc Morial and NAACP President and Chief Executive Officer Derrick Johnson.

James pointed out that while the federal government has given pharmaceutical companies billions of dollars to help develop vaccines for COVID-19, very little has been set aside to help states administer the vaccine when it becomes available.

Statistics show COVID-19 infection and death rates have been higher among communities of color for a myriad reasons, including poor access to health care, according the leaders on the call.

The federal plan to distribute vaccine relies on chain pharmacies and other sites where flu shots are currently available.

“You might see big chain pharmacies … every other block in communities in Manhattan but let’s be clear,” James said, “the neighborhoods where more of our communities of color live do now do not have this type of access and that’s the core of the federal plan.”

Morial and Johnson both said the federal government needs to explore the use of other sites for vaccinations, such as schools and community centers.

There were 2,255 new COVID-19 cases reported statewide Saturday including 141 in Nassau and 142 in Suffolk, according to statistics released by the state.

New York’s overall COVID-19 positivity rate is 1.5%, Cuomo said. In the red zones, neighborhoods with high infection rates, the positivity rate is 3.1%.

Across the state, 17 people died from COVID-19, including one person in Nassau and another in Suffolk, Cuomo said. There are 1,125 COVID-19 patients in hospitals statewide including 125 in intensive care units.

Cuomo said only less-densely populated Maine and Vermont have lower COVID-19 rates than New York.

“New Yorkers should be very proud of that,” he said. “We expect an increase in the fall but it’s managing the increase which is what this is all about.”

Source Article

Read more

How Much Biden’s Plan Will Cost Americans

Joe Biden says he is opposed to a single-payer healthcare system and instead favors a “public option,” which is a government-owned health insurance company.

In reality, there is no difference. 

A government entity would be subsidized. Private companies can’t compete with that. They would either go broke or be forced to fold their operations into the government company. Shareholders would be wiped out, and 180 million Americans would lose their current policies. 

Another downer—research and development for new drugs and medical devices to fight cancer, dementia and other ailments would suffer.

Follow me on TwitterSend me a secure tip

Steve Forbes is Chairman and Editor-in-Chief of Forbes Media.

Steve’s newest project is the podcast “What’s Ahead,” where he engages the world’s top newsmakers,

Steve Forbes is Chairman and Editor-in-Chief of Forbes Media.

Steve’s newest project is the podcast “What’s Ahead,” where he engages the world’s top newsmakers, politicians and pioneers in business and economics in honest conversations meant to challenge traditional conventions as well as featuring Steve’s signature views on the intersection of society, economic and policy.

Steve helped create the recently released and highly acclaimed public television documentary, In Money We Trust?, which was produced under the auspices of Maryland Public television. The film was inspired by the book he co-authored, Money: How the Destruction of the Dollar Threatens the Global Economy – and What We Can Do About It.

Steve’s latest book is Reviving America: How Repealing Obamacare, Replacing the Tax Code and Reforming The Fed will Restore Hope and Prosperity co-authored by Elizabeth Ames (McGraw-Hill Professional).

Steve writes editorials for each issue of Forbes under the heading of “Fact and Comment.” A widely respected economic prognosticator, he is the only writer to have won the highly prestigious Crystal Owl Award four times. The prize was formerly given by U.S. Steel Corporation to the financial journalist whose economic forecasts for the coming year proved most accurate.

In both 1996 and 2000, Steve campaigned vigorously for the Republican nomination for the Presidency. Key to his platform were a flat tax, medical savings accounts, a new Social Security system for working Americans, parental choice of schools for their children, term limits and a strong national defense. Steve continues to energetically promote this agenda.

Source Article

Read more

Utah hospitals plan on rationing care as coronavirus cases surge in the state: report

Hospitals in Utah will soon be forced begin prioritizing younger COVID-19 patients over older ones amid surging rate of hospitalizations from the virus in the state, doctors warned Utah’s governor on Thursday.

The Salt Lake Tribune reported that hospital administrators in the state asked Gov. Gary Herbert (R) to approve a plan that would take drastic steps to reduce intensive care unit (ICU) admissions in the event of hospital ICUs being overwhelmed, which they said was a serious possibility in the days ahead.

If ICUs are nearing capacity, patients who are not seen to be improving even with intensive care will be asked to consider moving to a regular hospital bed. Doctors will also be asked to clearly communicate with patients about do-not-resuscitate orders.

“These discussions on goals of care need to occur independently from triage decisions,” read the guidelines, according to the newspaper. “Providers must be careful not to coerce patients or their families.”

Once ICUs reach capacity, hospitals will take matters into their own hands to determine ICU priority, according to the Tribune. Lower priority will be given to patients who are older if two patients are otherwise equally eligible for an ICU bed, while those who are pregnant receive higher priority.

A spokesperson for Herbert’s office and other state officials confirmed to the Tribune and other news outlets that ICUs in the state are nearing capacity, but did not confirm if Herbert would approve the plan proposed by hospital administrators.

“Right now, it feels very close to being under the crisis standards of care. The [hospital administrators] were very clear about the level of stress that they’re under,” said Joe Dougherty, an official with Utah’s Division of Emergency Management. “We can have a public health order…but even with that in place, we still need people to choose to limit their gatherings.”

“We are not there yet, but we are too close, uncomfortably close,” added a spokesman for the governor.

Utah’s daily rate of new coronavirus cases is now double what it was at the peak of the first wave of cases earlier this year, with state officials reporting 1,543 new cases on Saturday, according to The New York Times. 319 patients are currently hospitalized across the state with the virus, while 568 deaths have been reported in the state since the pandemic began.

Source Article

Read more

Arizona’s COVID-19 vaccine plan suggests who may get priority


Pressure to create a coronavirus vaccine is increasing by the day, but for a safe vaccine to enter the market, it takes time.


Arizona’s COVID-19 vaccine plan doesn’t say for certain who gets immunized first when vaccines roll out, but the working document suggests priority will go to a broad category of health care workers.

Officials with the Arizona Department of Health Services recently submitted its draft coronavirus vaccine plan to the U.S. Centers for Disease Control and Prevention, which was a requirement for all states.

The state plans were due Oct. 16. Arizona’s draft plan builds off a model it used during the H1N1 (swine flu) pandemic of 2009. Arizona’s plan will be updated as more details are provided to the state from federal partners, state health officials say.

A more detailed “operational” vaccine plan is expected to be completed further along in the process. State health officials say they don’t have a definitive date for when that plan will be released.

In Thursday’s presidential debate, President Donald Trump said there was a COVID-19 vaccine “that’s ready.”

But experts say it’s unlikely a vaccine will be available until the end of the year, and many place wide distribution at sometime in 2021. To date, no COVID-19 vaccine has been approved by the FDA, either through the regular approval process or by emergency use authorization.

Who might be immunized first?

While more than one COVID-19 vaccine may become available, there might not be enough supply to initially go around. That’s why government officials need to consider who to immunize first, and the ways that they will distribute it.

The state plan references priority populations outlined in the CDC’s COVID-19 Vaccination Interim Playbook released in September, as well as guidance contained in a federal report released earlier this month.

Both the CDC playbook and the National Academies of Sciences, Engineering and Medicine report prioritize health care workers and first responders during the first phase of the vaccine rollout.

A state worksheet in the draft plan lists the priority order by category for receiving vaccines, before it would go to the general population:

  • 1a: Health care personnel, among them pharmacists, pharmacy techs, school nurses, home health aides, health care support workers, practitioners and first responders.
  • 1b: Other essential workers such as food industry workers, teachers and child care workers.
  • 1b: People at increased risk for COVID-19 illness, including people age 65 and older.
  • 2: People at increased risk of acquiring or transmitting the coronavirus, such as individuals attending colleges and universities and racial and ethnic minority groups.
  • 2: People with limited access to routine vaccination services, including people with disabilities and people who don’t speak English.

“While target groups and prioritization tiers may differ somewhat for each local jurisdiction, this worksheet will assist in estimations and reinforce key planning elements,” Arizona Department of Health Services spokesman Steve Elliott wrote in an email.

The state plan, CDC playbook and NASEM report all reference health inequities that need to be addressed

Read more

State reports more than 1,100 new coronavirus cases, prompting calls for a new state plan

The 1,128 new cases reported Saturday represented the highest one-day hike since late May and along with the growing number were demands the state start laying out what officials plan to do as the weather grows colder and people gather indoors more frequently.

Dr. Robert Horsburgh, a professor of epidemiology at Boston University, expressed frustration Saturday that the state hasn’t rolled out specific plans, even as the governor anticipates more cases.

“He hasn’t told us what his plan was. He’s confident that they can handle it, great. But what’s the plan?” Horsburgh said.

The latest number of new cases “means more people are catching it, and we should be thinking about how to stop it, otherwise we’ll end up looking like Wisconsin,” Horsburgh said.

Dr. Sam Scarpino, a Northeastern University epidemiologist, said scientists have some evidence that the coronavirus could spread more easily in colder, drier weather.

“It could be that we’re going to have to make modifications as we go into the winter,” Scarpino said of the state’s ongoing reopening effort. “And far as I can tell, we don’t have a clear plan for that being communicated from the state around what the triggers would be [and] what they would target first.”

The increase reported Saturday brought the state’s total number of confirmed cases of COVID-19 to 146,023, according to state data from the state Department of Public Health.

The death toll in Massachusetts due to confirmed cases of the coronavirus totaled 9,616 as of Saturday, according to the state.

The most recent three-day average of new COVID-19 deaths, for Wednesday, was 19, the state reported Saturday.

The latest figures from state officials also come after the US coronavirus caseload grew by more than 83,000 new cases Friday, according to the Associated Press.

Across the United States, nearly 225,000 people have died from the virus, and more than 8.5 million cases have been reported, according to Johns Hopkins University Saturday.

On Saturday, the state reported 19,168 new people received molecular tests for the virus, bringing the total number of people who received that test to more than 2.6 million.

The state’s seven-day average positive rate, calculated from all those tests administered, was at 1.5 percent Friday, the state reported Saturday. That figure has steadily increased since late last month, when the state reported a rate below 1 percent.

A separate measure of positivity that is based on daily positive tests per people tested was at 6.6 percent Thursday, according to the state. That daily rate can fluctuate, and has dipped as low as 3.3 percent earlier in October. But it has been on an upward trajectory since mid-September, when that rate ranged between 1.8 percent and 2.9 percent, according to state data.

In separate phone interviews, both Horsburgh and Scarpino criticized the state for not releasing further details about COVID-19 infections — data both experts said is critical to stopping the spread of the virus.

Apart from the latest state data, Scarpino pointed to other signs of the virus’s

Read more

South Korean authorities stick to flu vaccine plan after deaths rise to 48

By Heekyong Yang

SEOUL (Reuters) – The number of South Koreans who have died after getting flu shots has risen to 48, the Korea Disease Control and Prevention Agency (KDCA) said on Saturday, adding that the vaccines would continue to reduce the chance of having simultaneous epidemics.

The health authorities said they found no direct link between the deaths and the shots. They plan to carry on with the state-run vaccination programme to try to avoid having to fight both the flu and the coronavirus over the coming winter.

“After reviewing death cases so far, it is not the time to suspend a flu vaccination programme since vaccination is very crucial this year, considering … the COVID-19 outbreaks,” KDCA Director Jeong Eun-kyung told a briefing.

Jeong said the review had shown no direct link between the flu shots and the 26 deaths that have been investigated.

Some 20 initial autopsy results from the police and the National Forensic Service showed that 13 people died of cardiovascular, cerebrovascular and other disorders not caused by the vaccination.

The death toll among those who have been vaccinated rose by 12 cases from a day earlier to 48 on Saturday.

The rising deaths have caused some doctors and politicians to call for a halt to the government campaign to vaccinate about 30 million of the country’s 54 million people.

While encouraging people to get flu vaccines, Jeong issued precautions to take before getting the shot, such as drinking enough water and telling healthcare workers about any underlying medical conditions. She also advised people to wait 15-30 minutes before leaving the clinic where they receive their vaccine.

“If possible, try to get the flu shot when it’s warm, since there are concerns that low temperatures could affect cardiovascular disease or cerebrovascular disease,” she said.

The KDCA said 9.4 million people had been inoculated as of Friday in the programme that began in September, with 1,154 cases of adverse reactions.

South Korea reported 77 new coronavirus cases as of Friday midnight, bringing total infections to 25,775, with 457 deaths.

(Reporting by Heekyong Yang; Editing by Tom Hogue)

Source Article

Read more

The Trump Administration Shut a Vaccine Safety Office Last Year. What’s the Plan Now?

As the first coronavirus vaccines arrive in the coming year, government researchers will face a monumental challenge: monitoring the health of hundreds of millions of Americans to ensure the vaccines don’t cause harm.

Purely by chance, thousands of vaccinated people will have heart attacks, strokes and other illnesses shortly after the injections. Sorting out whether the vaccines had anything to do with their ailments will be a thorny problem, requiring a vast, coordinated effort by state and federal agencies, hospitals, drug makers and insurers to discern patterns in a flood of data. Findings will need to be clearly communicated to a distrustful public swamped with disinformation.

For now, Operation Warp Speed, created by the Trump administration to spearhead development of coronavirus vaccines and treatments, is focused on getting vaccines through clinical trials in record time and manufacturing them quickly.

The next job will be to monitor the safety of vaccines once they’re in widespread use. But the administration last year quietly disbanded the office with the expertise for exactly this job. Its elimination has left that long-term safety effort for coronavirus vaccines fragmented among federal agencies, with no central leadership, experts say.

“We’re behind the eight ball,” said Daniel Salmon, who served as the director of vaccine safety in that office from 2007 to 2012, overseeing coordination during the H1N1 flu pandemic in 2009. ”We don’t even know who’s in charge.”

An H.H.S. spokeswoman declined to answer detailed questions about why the vaccine office, set up in 1987, was closed or how the health agencies were planning to track the safety of vaccines once they are injected into millions of people. In a brief statement, she said that Operation Warp Speed was working closely with the Centers for Disease Control and Prevention “to synchronize the IT systems” involved in monitoring vaccine safety data.

Scientists at the C.D.C. and the Food and Drug Administration have decades of experience tracking the long-term safety of vaccines. They’ve created powerful computer programs that can analyze large databases.

“It’s like satellites looking at the weather,” said Dr. Bruce Gellin, the president of the Sabin Vaccine Institute, who headed the National Vaccine Program Office from 2002 to 2017.

But monitoring hundreds of millions of Americans who may get different coronavirus vaccines from a variety of drug makers by summer is like tracking a major storm beyond anything researchers have dealt with before.

The closest parallel was in the spring of 2009, when a new strain of H1N1 influenza emerged, and researchers raced to make a vaccine. From October 2009 to January 2010, it was administered to over 82 million people in the United States.

As the vaccine was developed, Dr. Gellin and other federal officials and scientists organized a system to monitor the population for severe side effects and to promptly share results with the public. Eleven years later, it looks like the lessons of 2009 are being forgotten, experts say.

“We got all these different agencies together, we created governance around it, we created a

Read more
  • Partner links